# Etsy Inc: financial statements, quarterly

ETSY · NYSE · CIK 1370637 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/etsy.md) · [Financials](/companies/etsy/financials.md) · [Filings](/companies/etsy/filings.md) · [Insiders](/companies/etsy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/etsy/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [842 d](/filings/0001370637-26-000019.md) | [646](/filings/0001370637-25-000040.md) | [648](/filings/0001370637-25-000066.md) | [662](/filings/0001370637-25-000100.md) | [852 d](/filings/0001370637-26-000019.md) | [612](/filings/0001370637-26-000044.md) | [629](/filings/0001370637-26-000080.md) | [624](/filings/0001370637-26-000092.md) | [1,018 d](/filings/0001370637-26-000019.md) | [631](/filings/0001370637-26-000044.md) | [668](/filings/0001370637-26-000080.md) | [692](/filings/0001370637-26-000092.md) |
| Cost of revenue | $m | [256 d](/filings/0001370637-26-000019.md) | [187](/filings/0001370637-25-000040.md) | [184](/filings/0001370637-25-000066.md) | [186](/filings/0001370637-25-000100.md) | [218 d](/filings/0001370637-26-000019.md) | [168](/filings/0001370637-26-000044.md) | [169](/filings/0001370637-26-000080.md) | [166](/filings/0001370637-26-000092.md) | [315 d](/filings/0001370637-26-000019.md) | [176](/filings/0001370637-26-000044.md) | [184](/filings/0001370637-26-000080.md) | [189](/filings/0001370637-26-000092.md) |
| Gross profit | $m | [587 d](/filings/0001370637-26-000019.md) | [459](/filings/0001370637-25-000040.md) | [464](/filings/0001370637-25-000066.md) | [477](/filings/0001370637-25-000100.md) | [634 d](/filings/0001370637-26-000019.md) | [444](/filings/0001370637-26-000044.md) | [461](/filings/0001370637-26-000080.md) | [458](/filings/0001370637-26-000092.md) | [703 d](/filings/0001370637-26-000019.md) | [456](/filings/0001370637-26-000044.md) | [484](/filings/0001370637-26-000080.md) | [503](/filings/0001370637-26-000092.md) |
| Research and development | $m | [117 d](/filings/0001370637-26-000019.md) | [110](/filings/0001370637-25-000040.md) | [114](/filings/0001370637-25-000066.md) | [107](/filings/0001370637-25-000100.md) | [111 d](/filings/0001370637-26-000019.md) | [101](/filings/0001370637-26-000044.md) | [99.3](/filings/0001370637-26-000080.md) | [99.8](/filings/0001370637-26-000092.md) | [150 d](/filings/0001370637-26-000019.md) | [99.1](/filings/0001370637-26-000044.md) | [101](/filings/0001370637-26-000080.md) | [111](/filings/0001370637-26-000092.md) |
| Operating income | $m | [115 d](/filings/0001370637-26-000019.md) | [68.1](/filings/0001370637-25-000040.md) | [70.2](/filings/0001370637-25-000066.md) | [86.8](/filings/0001370637-25-000100.md) | [155 d](/filings/0001370637-26-000019.md) | [(3.9)](/filings/0001370637-26-000044.md) | [94.1](/filings/0001370637-26-000080.md) | [111](/filings/0001370637-26-000092.md) | [65.0 d](/filings/0001370637-26-000019.md) | [120](/filings/0001370637-26-000044.md) | [125](/filings/0001370637-26-000080.md) | [111](/filings/0001370637-26-000092.md) |
| Interest expense | $m | not reported | not reported | [3.5](/filings/0001370637-25-000066.md) | [3.4](/filings/0001370637-25-000100.md) | [3.4 d](/filings/0001370637-26-000019.md) | not reported | [3.8](/filings/0001370637-26-000080.md) | [5.7](/filings/0001370637-26-000092.md) | [5.6 d](/filings/0001370637-26-000019.md) | not reported | [5.6](/filings/0001370637-26-000080.md) | [5.6](/filings/0001370637-26-000092.md) |
| Income tax | $m | [25.9 d](/filings/0001370637-26-000019.md) | [16.7](/filings/0001370637-25-000040.md) | [26.0](/filings/0001370637-25-000066.md) | [16.4](/filings/0001370637-25-000100.md) | [48.4 d](/filings/0001370637-26-000019.md) | [20.5](/filings/0001370637-26-000044.md) | [23.3](/filings/0001370637-26-000080.md) | [15.6](/filings/0001370637-26-000092.md) | [24.4 d](/filings/0001370637-26-000019.md) | [24.6](/filings/0001370637-26-000044.md) | [20.6](/filings/0001370637-26-000080.md) | [15.1](/filings/0001370637-26-000092.md) |
| Net income | $m | [83.3 d](/filings/0001370637-26-000019.md) | [63.0](/filings/0001370637-25-000040.md) | [53.0](/filings/0001370637-25-000066.md) | [57.4](/filings/0001370637-25-000100.md) | [130 d](/filings/0001370637-26-000019.md) | [(52.1)](/filings/0001370637-26-000044.md) | [28.8](/filings/0001370637-26-000080.md) | [75.5](/filings/0001370637-26-000092.md) | [111 d](/filings/0001370637-26-000019.md) | [69.7](/filings/0001370637-26-000044.md) | [(46.7)](/filings/0001370637-26-000080.md) | [854](/filings/0001370637-26-000092.md) |
| Diluted EPS | $ per share | not reported | [0.48](/filings/0001370637-25-000040.md) | [0.41](/filings/0001370637-25-000066.md) | [0.45](/filings/0001370637-25-000100.md) | not reported | [(0.49)](/filings/0001370637-26-000044.md) | [0.25](/filings/0001370637-26-000080.md) | [0.63](/filings/0001370637-26-000092.md) | not reported | [0.60](/filings/0001370637-26-000044.md) | [(0.36)](/filings/0001370637-26-000080.md) | [7.31](/filings/0001370637-26-000092.md) |
| Basic EPS | $ per share | not reported | [0.53](/filings/0001370637-25-000040.md) | [0.46](/filings/0001370637-25-000066.md) | [0.50](/filings/0001370637-25-000100.md) | not reported | [(0.49)](/filings/0001370637-26-000044.md) | [0.28](/filings/0001370637-26-000080.md) | [0.76](/filings/0001370637-26-000092.md) | not reported | [0.72](/filings/0001370637-26-000044.md) | [(0.49)](/filings/0001370637-26-000080.md) | [9.37](/filings/0001370637-26-000092.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [914](/filings/0001370637-26-000019.md) | [789](/filings/0001370637-24-000030.md) | [759](/filings/0001370637-24-000043.md) | [819](/filings/0001370637-25-000100.md) | [811](/filings/0001370637-26-000019.md) | [618](/filings/0001370637-26-000044.md) | [1,155](/filings/0001370637-26-000080.md) | [1,208](/filings/0001370637-26-000092.md) | [1,355](/filings/0001370637-26-000092.md) | [1,214](/filings/0001370637-26-000044.md) | [901](/filings/0001370637-26-000080.md) | [2,066](/filings/0001370637-26-000092.md) |
| Current assets | $m | [1,570](/filings/0001370637-25-000017.md) | [1,404](/filings/0001370637-24-000030.md) | [1,359](/filings/0001370637-24-000043.md) | [1,321](/filings/0001370637-24-000051.md) | [1,328](/filings/0001370637-26-000019.md) | [1,110](/filings/0001370637-25-000040.md) | [1,648](/filings/0001370637-25-000066.md) | [1,794](/filings/0001370637-25-000100.md) | [1,961](/filings/0001370637-26-000092.md) | [2,113](/filings/0001370637-26-000044.md) | [1,875](/filings/0001370637-26-000080.md) | [2,603](/filings/0001370637-26-000092.md) |
| Total assets | $m | [2,685](/filings/0001370637-25-000017.md) | [2,498](/filings/0001370637-24-000030.md) | [2,448](/filings/0001370637-24-000043.md) | [2,442](/filings/0001370637-24-000051.md) | [2,418](/filings/0001370637-26-000019.md) | [2,121](/filings/0001370637-25-000040.md) | [2,557](/filings/0001370637-25-000066.md) | [2,653](/filings/0001370637-25-000100.md) | [2,827](/filings/0001370637-26-000092.md) | [2,681](/filings/0001370637-26-000044.md) | [2,439](/filings/0001370637-26-000080.md) | [3,168](/filings/0001370637-26-000092.md) |
| Current liabilities | $m | [711](/filings/0001370637-25-000017.md) | [565](/filings/0001370637-24-000030.md) | [564](/filings/0001370637-24-000043.md) | [553](/filings/0001370637-24-000051.md) | [665](/filings/0001370637-26-000019.md) | [519](/filings/0001370637-25-000040.md) | [486](/filings/0001370637-25-000066.md) | [565](/filings/0001370637-25-000100.md) | [1,364](/filings/0001370637-26-000092.md) | [1,251](/filings/0001370637-26-000044.md) | [1,270](/filings/0001370637-26-000080.md) | [1,916](/filings/0001370637-26-000092.md) |
| Total liabilities | $m | [3,229](/filings/0001370637-25-000017.md) | [3,081](/filings/0001370637-24-000030.md) | [3,083](/filings/0001370637-24-000043.md) | [3,067](/filings/0001370637-24-000051.md) | [3,177](/filings/0001370637-26-000019.md) | [3,031](/filings/0001370637-25-000040.md) | [3,682](/filings/0001370637-25-000066.md) | [3,765](/filings/0001370637-25-000100.md) | [3,925](/filings/0001370637-26-000092.md) | [3,818](/filings/0001370637-26-000044.md) | [3,834](/filings/0001370637-26-000080.md) | [3,846](/filings/0001370637-26-000092.md) |
| Long-term debt | $m | [2,284](/filings/0001370637-25-000017.md) | [2,285](/filings/0001370637-24-000030.md) | [2,286](/filings/0001370637-24-000043.md) | [2,287](/filings/0001370637-24-000051.md) | [2,288](/filings/0001370637-26-000019.md) | [2,289](/filings/0001370637-25-000040.md) | [2,979](/filings/0001370637-25-000066.md) | [2,981](/filings/0001370637-25-000100.md) | [2,333](/filings/0001370637-26-000092.md) | [2,335](/filings/0001370637-26-000044.md) | [2,336](/filings/0001370637-26-000080.md) | [1,688](/filings/0001370637-26-000092.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001370637-26-000019.md) | not reported | not reported | not reported | [649](/filings/0001370637-26-000092.md) | [649](/filings/0001370637-26-000044.md) | [650](/filings/0001370637-26-000080.md) | [1,299](/filings/0001370637-26-000092.md) |
| Shareholders' equity | $m | [(544)](/filings/0001370637-26-000019.md) | [(584)](/filings/0001370637-25-000066.md) | [(635)](/filings/0001370637-25-000100.md) | [(624)](/filings/0001370637-25-000100.md) | [(759)](/filings/0001370637-26-000092.md) | [(910)](/filings/0001370637-26-000080.md) | [(1,125)](/filings/0001370637-26-000092.md) | [(1,113)](/filings/0001370637-26-000092.md) | [(1,098)](/filings/0001370637-26-000092.md) | [(1,137)](/filings/0001370637-26-000080.md) | [(1,395)](/filings/0001370637-26-000092.md) | [(678)](/filings/0001370637-26-000092.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [295 d](/filings/0001370637-26-000019.md) | [69.0](/filings/0001370637-25-000040.md) | [151 d](/filings/0001370637-25-000066.md) | [217 d](/filings/0001370637-25-000100.md) | [315 d](/filings/0001370637-26-000019.md) | [49.2](/filings/0001370637-26-000044.md) | [108 d](/filings/0001370637-26-000080.md) | [219 d](/filings/0001370637-26-000092.md) | [317 d](/filings/0001370637-26-000019.md) | [80.7](/filings/0001370637-26-000044.md) | [40.6 d](/filings/0001370637-26-000080.md) | [160 d](/filings/0001370637-26-000092.md) |
| Capital expenditure | $m | [5.2 d](/filings/0001370637-26-000019.md) | [2.3](/filings/0001370637-25-000040.md) | [3.7 d](/filings/0001370637-25-000066.md) | [4.3 d](/filings/0001370637-25-000100.md) | [4.0 d](/filings/0001370637-26-000019.md) | [3.2](/filings/0001370637-26-000044.md) | [6.9 d](/filings/0001370637-26-000080.md) | [3.8 d](/filings/0001370637-26-000092.md) | [1.5 d](/filings/0001370637-26-000019.md) | [1.5](/filings/0001370637-26-000044.md) | [1.2 d](/filings/0001370637-26-000080.md) | [1.4 d](/filings/0001370637-26-000092.md) |
| Share repurchases | $m | [93.0 d](/filings/0001370637-26-000019.md) | [158](/filings/0001370637-25-000040.md) | [150 d](/filings/0001370637-25-000066.md) | [156 d](/filings/0001370637-25-000100.md) | [260 d](/filings/0001370637-26-000019.md) | [189](/filings/0001370637-26-000044.md) | [335 d](/filings/0001370637-26-000080.md) | [120 d](/filings/0001370637-26-000092.md) | [133 d](/filings/0001370637-26-000019.md) | [145](/filings/0001370637-26-000044.md) | [250 d](/filings/0001370637-26-000080.md) | [395 d](/filings/0001370637-26-000092.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [143](/filings/0001370637-24-000030.md) | [141](/filings/0001370637-24-000043.md) | [139](/filings/0001370637-24-000051.md) | [135](/filings/0001370637-25-000040.md) | [133](/filings/0001370637-25-000066.md) | [131](/filings/0001370637-25-000100.md) | [107](/filings/0001370637-26-000044.md) | [122](/filings/0001370637-26-000080.md) | [125](/filings/0001370637-26-000092.md) | [121](/filings/0001370637-26-000044.md) | [120](/filings/0001370637-26-000080.md) | [117](/filings/0001370637-26-000092.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 86,205,886 at 2026-10-23, from the cover of the [10-Q filed 2026-10-28](/filings/0001370637-26-000092.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 28, 2026, 08:33 ET. No prices; not investment advice.